Catechol-O-methyl transferase modulates cognition in late life: Evidence and implications for cognitive enhancement

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 3, 2012, Pages 195-208

  Sambataro, Fabio ^a   Pennuto, Maria ^a   Wolf, Robert Christian ^b  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aging; Catechol O methyl transferase; Catechol O methyl transferase inhibitors; Cognition; Dopamine

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE; DOPAMINE TRANSPORTER; ESTRADIOL; TYROSINE 3 MONOOXYGENASE;

AGED; AGING; ATTENTION; BRAIN FUNCTION; CAUCASIAN; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COGNITION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINERGIC ACTIVITY; ENZYME ACTIVITY; EPISODIC MEMORY; EXECUTIVE FUNCTION; GENE INTERACTION; GENETIC EPISTASIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTELLIGENCE QUOTIENT; MENTAL HEALTH; METHYLATION; MINI MENTAL STATE EXAMINATION; MOOD; PARKINSON DISEASE; PERSONALITY; PLEIOTROPY; PROTEIN EXPRESSION; RESPONSE TIME; REVIEW; SEMANTIC MEMORY; SEX DIFFERENCE; SIGNAL TRANSDUCTION; WISCONSIN CARD SORTING TEST; WORKING MEMORY;

EID: 84861797593     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152712800672463     Document Type: Review

References (120)

1. Murty, V.P.; Sambataro, F.; Das, S.; Tan, H.Y.; Callicott, J.H.; Goldberg, T.E.; Meyer-Lindenberg, A.; Weinberger, D.R.; Mattay, V.S. Age-related alterations in simple declarative memory and the effect of negative stimulus valence. J. Cogn. Neurosci., 2009, 21(10), 1920-1933.
2. Whalley, L.J.; Deary, I.J.; Appleton, C.L.; Starr, J.M. Cognitive reserve and the neurobiology of cognitive aging. Ageing Res. Rev., 2004, 3(4), 369-382.
3. Courchesne, E.; Chisum, H.J.; Townsend, J.; Cowles, A.; Covington, J.; Egaas, B.; Harwood, M.; Hinds, S.; Press, G.A. Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology, 2000, 216(3), 672-682.
4. Good, C.D.; Johnsrude, I.S.; Ashburner, J.; Henson, R.N.; Friston, K.J.; Frackowiak, R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage, 2001, 14(1 Pt 1), 21-36.
5. Lemaitre, H.; Crivello, F.; Grassiot, B.; Alperovitch, A.; Tzourio, C.; Mazoyer, B. Ageand sex-related effects on the neuroanatomy of healthy elderly. Neuroimage, 2005, 26(3), 900-911.
6. Lemaitre, H.; Goldman, A.L.; Sambataro, F.; Verchinski, B.A.; Meyer-Lindenberg, A.; Weinberger, D.R.; Mattay, V.S. Normal age-related brain morphometric changes: nonuniformity across cortical thickness, surface area and gray matter volume? Neurobiol. Aging, 2012, 33(3), 617.e1-9.
7. Smith, C.D.; Chebrolu, H.; Wekstein, D.R.; Schmitt, F.A.; Markesbery, W.R. Age and gender effects on human brain anatomy: a voxel-based morphometric study in healthy elderly. Neurobiol. Aging, 2007, 28(7), 1075-1087.
8. Walhovd, K.B.; Fjell, A.M.; Reinvang, I.; Lundervold, A.; Dale, A.M.; Eilertsen, D.E.; Quinn, B.T.; Salat, D.; Makris, N.; Fischl, B. Effects of age on volumes of cortex, white matter and subcortical structures. Neurobiol. Aging, 2005, 26(9), 1261-1270; discussion 1275-1278.
9. Raz, N.; Rodrigue, K.M. Differential aging of the brain: patterns, cognitive correlates and modifiers. Neurosci. Biobehav. Rev., 2006, 30(6), 730-748.
10. Sambataro, F.; Safrin, M.; Lemaitre, H.; Steele, S.U.; Das, S.; Callicott, J.H.; Weinberger, D.R.; Mattay, V. Aging modulates prefrontoparietal networks underlying multiple memory processes, in review.
11. Cools, R.; D'Esposito, M. Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol. Psychiatry, 2011, 69(12), e113-125.
12. Sambataro, F.; Pennuto, M. Cell-autonomous and non-cellautonomous toxicity in polyglutamine diseases. Prog. In Neurobiol., in press. Avaialble at: http://dx.doi.org/10.1016/j.pneurobio.2011.10.003.
13. Di Giorgio, A.; Sambataro, F.; Bertolino, A. Functional imaging as a tool to investigate the relationship between genetic variation and response to treatment with antipsychotics. Curr. Pharm. Des., 2009, 15(22), 2560-2572.
14. Sambataro, F.; Murty, V.P.; Callicott, J.H.; Tan, H.Y.; Das, S.; Weinberger, D.R.; Mattay, V.S. Age-related alterations in default mode network: impact on working memory performance. Neurobiol. Aging, 2010, 31(5), 839-852.
15. Bäckman, L.; Nyberg, L.; Lindenberger, U.; Li, S.C.; Farde, L. The correlative triad among aging, dopamine, and cognition: Current status and future prospects. Neurosci. Biobehav. Rev., 2006, 30(6), 791-807.
16. Reeves, S.; Bench, C.; Howard, R. Ageing and the nigrostriatal dopaminergic system. Int. J. Geriatr. Psychiatry, 2002, 17(4), 359-370.
17. Frey, K.A.; Koeppe, R.A.; Kilbourn, M.R.; Vander Borght, T.M.; Albin, R.L.; Gilman, S.; Kuhl, D.E. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann. Neurol., 1996, 40(6), 873-884.
18. Troiano, A.R.; Schulzer, M.; de la Fuente-Fernandez, R.; Mak, E.; McKenzie, J.; Sossi, V.; McCormick, S.; Ruth, T.J.; Stoessl, A.J. Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function. Synapse, 2010, 64(2), 146-151.
19. Rieckmann, A.; Karlsson, S.; Karlsson, P.; Brehmer, Y.; Fischer, H.; Farde, L.; Nyberg, L.; Backman, L. Dopamine D1 Receptor Associations within and between Dopaminergic Pathways in Younger and Elderly Adults: Links to Cognitive Performance. Cereb. Cortex, 2011, 21(9), 2023-2032.
20. Wang, Y.; Chan, G.L.; Holden, J.E.; Dobko, T.; Mak, E.; Schulzer, M.; Huser, J.M.; Snow, B.J.; Ruth, T.J.; Calne, D.B.; Stoessl, A.J. Age-dependent decline of dopamine D1 receptors in human brain: a PET study. Synapse, 1998, 30(1), 56-61.
21. Antonini, A.; Leenders, K.L. Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride. Ann. NY Acad. Sci., 1993, 695, 81-85.
22. Backman, L.; Ginovart, N.; Dixon, R.A.; Wahlin, T.B.; Wahlin, A.; Halldin, C.; Farde, L. Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am. J. Psychiatry, 2000, 157(4), 635-637.
23. Harada, N.; Nishiyama, S.; Satoh, K.; Fukumoto, D.; Kakiuchi, T.; Tsukada, H. Age-related changes in the striatal dopaminergic system in the living brain: a multiparametric PET study in conscious monkeys. Synapse, 2002, 45(1), 38-45.
24. Ishibashi, K.; Ishii, K.; Oda, K.; Kawasaki, K.; Mizusawa, H.; Ishiwata, K. Regional analysis of age-related decline in dopamine transporters and dopamine D2-like receptors in human striatum. Synapse, 2009, 63(4), 282-290.
25. Morris, E.D.; Chefer, S.I.; Lane, M.A.; Muzic, R.F. Jr.; Wong, D.F.; Dannals, R.F.; Matochik, J.A.; Bonab, A.A.; Villemagne, V.L.; Grant, S.J.; Ingram, D.K.; Roth, G.S.; London, E.D. Loss of D2 receptor binding with age in rhesus monkeys: importance of correction for differences in striatal size. J. Cereb. Blood Flow Metab., 1999, 19(2), 218-229.
26. Pohjalainen, T.; Rinne, J.O.; Nagren, K.; Syvalahti, E.; Hietala J. Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. Am. J. Psychiatry, 1998, 155(6), 768-773.
27. Rinne, J.O.; Hietala J. Ruotsalainen, U.; Sako, E.; Laihinen, A.; Nagren, K.; Lehikoinen, P.; Oikonen, V.; Syvalahti, E. Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride. J. Cereb. Blood Flow Metab., 1993, 13(2), 310-314.
28. Seeman, P.; Bzowej, N.H.; Guan, H.C.; Bergeron, C.; Becker, L.E.; Reynolds, G.P.; Bird, E.D.; Riederer, P.; Jellinger, K.; Watanabe, S.; et al. Human brain dopamine receptors in children and aging adults. Synapse, 1987, 1(5), 399-404.
29. Volkow, N.D.; Gur, R.C.; Wang, G.J.; Fowler, J.S.; Moberg, P.J.; Ding, Y.S.; Hitzemann, R.; Smith, G.; Logan, J. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am. J. Psychiatry, 1998, 155(3), 344-349.
30. Wang, G.J.; Volkow, N.D.; Logan, J.; Fowler, J.S.; Schlyer, D.; MacGregor, R.R.; Hitzemann, R.J.; Gur, R.C.; Wolf, A.P. Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects. Life Sci., 1995, 56(14), 249-253.
31. Wong, D.F.; Wagner, H.N. Jr.; Dannals, R.F.; Links, J.M.; Frost, J.J.; Ravert, H.T.; Wilson, A.A.; Rosenbaum, A.E.; Gjedde, A.; Douglass, K.H.; et al. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science, 1984, 226(4681), 1393-1396.
32. Kaasinen, V.; Vilkman, H.; Hietala J Nagren, K.; Helenius, H.; Olsson, H.; Farde, L.; Rinne, J. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Neurobiol. Aging, 2000, 21(5), 683-688.
33. Lewis, D.A.; Sesack, S.R.; Levey, A.I.; Rosenberg, D.R. Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development. Adv. Pharmacol., 1998, 42, 703-706.
34. Sesack, S.R.; Hawrylak, V.A.; Matus, C.; Guido, M.A.; Levey, A.I. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci., 1998, 18(7), 2697-2708.
35. Karoum, F.; Chrapusta, S.J.; Egan, M.F. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J. Neurochem., 1994, 63(3), 972-979.
36. Lachman, H.M.; Papolos, D.F.; Saito, T.; Yu, Y.M.; Szumlanski, C.L.; Weinshilboum, R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 1996, 6(3), 243-250.
37. Egan, M.F.; Goldberg, T.E.; Kolachana, B.S.; Callicott, J.H.; Mazzanti, C.M.; Straub, R.E.; Goldman, D.; Weinberger, D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. USA, 2001, 98(12), 6917-6922.
38. Barnett, J.H.; Jones, P.B.; Robbins, T.W.; Muller, U. Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol. Psychiatry, 2007, 12(5), 502-509.
39. Barnett, J.H.; Scoriels, L.; Munafo, M.R. Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol. Psychiatry, 2008, 64(2), 137-144.
40. Papaleo, F.; Crawley, J.N.; Song, J.; Lipska, B.K.; Pickel, J.; Weinberger, D.R.; Chen, J. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J. Neurosci., 2008, 28(35), 8709-8723.
41. Harris, S.E.; Wright, A.F.; Hayward, C.; Starr, J.M.; Whalley, L.J.; Deary, I.J. The functional COMT polymorphism, Val 158 Met, is associated with logical memory and the personality trait intellect/imagination in a cohort of healthy 79 year olds. Neurosci. Lett., 2005, 385(1), 1-6.
42. Raz, N.; Rodrigue, K.M.; Kennedy, K.M.; Land, S. Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension. Neuropsychology, 2009, 23(1), 105-116.
43. Holtzer, R.; Ozelius, L.; Xue, X.; Wang, T.; Lipton, R.B.; Verghese, J. Differential effects of COMT on gait and executive control in aging. Neurobiol. Aging, 2011, 31(3), 523-531.
44. Nagel, I.E.; Chicherio, C.; Li, S.C.; von Oertzen, T.; Sander, T.; Villringer, A.; Heekeren, H.R.; Backman, L.; Lindenberger, U. Human aging magnifies genetic effects on executive functioning and working memory. Front. Hum. Neurosci., 2008, 2, 1.
45. Milner, B. Effects of different brain lesions on card sorting. Arch. Neurol., 1963, 9, 90-100.
46. de Frias, C.M.; Annerbrink, K.; Westberg, L.; Eriksson, E.; Adolfsson, R.; Nilsson, L.G. Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults. J. Cogn. Neurosci., 2005, 17(7), 1018-1025.
47. Liu, M.E.; Hong, C.J.; Liou, Y.J.; Tsai, Y.L.; Hsieh, C.H.; Tsai, S.J. Association study of a functional catechol-O-methyltransferase polymorphism and executive function in elderly males without dementia. Neurosci. Lett., 2008, 436(2), 193-195.
48. de Frias, C.M.; Annerbrink, K.; Westberg, L.; Eriksson, E.; Adolfsson, R.; Nilsson, L.G. COMT gene polymorphism is associated with declarative memory in adulthood and old age. Behav. Genet., 2004, 34(5), 533-539.
49. Potter, G.G.; Taylor, W.D.; McQuoid, D.R.; Steffens, D.C.; Welsh-Bohmer, K.A.; Krishnan, K.R. The COMT Val158Met polymorphism and cognition in depressed and nondepressed older adults. Int. J. Geriatr. Psychiatry, 2009, 24(10), 1127-1133.
50. Raz, N.; Dahle, C.L.; Rodrigue, K.M.; Kennedy, K.M.; Land, S. Effects of age, genes, and pulse pressure on executive functions in healthy adults. Neurobiol. Aging, 2011, 32(6), 1124-1137.
51. O'Hara, R.; Miller, E.; Liao, C.P.; Way, N.; Lin, X.; Hallmayer, J. COMT genotype, gender and cognition in community-dwelling, older adults. Neurosci. Lett., 2006, 409(3), 205-209.
52. Starr, J.M.; Fox, H.; Harris, S.E.; Deary, I.J.; Whalley, L.J. COMT genotype and cognitive ability: a longitudinal aging study. Neurosci. Lett., 2007, 421(1), 57-61.
53. Erickson, K.I.; Kim, J.S.; Suever, B.L.; Voss, M.W.; Francis, B.M.; Kramer, A.F. Genetic contributions to age-related decline in executive function: a 10-year longitudinal study of COMT and BDNF polymorphisms. Front. Hum. Neurosci., 2008, 2, 11.
54. Fiocco, A.J.; Lindquist, K.; Ferrell, R.; Li, R.; Simonsick, E.M.; Nalls, M.; Harris, T.B.; Yaffe, K. COMT genotype and cognitive function: an 8-year longitudinal study in white and black elders. Neurology, 2011, 74(16), 1296-1302.
55. Salthouse, T.A. What do adult age differences in the Digit Symbol Substitution Test reflect? J. Gerontol., 1992, 47(3), P121-128.
56. Dumontheil, I.; Roggeman, C.; Ziermans, T.; Peyrard-Janvid, M.; Matsson, H.; Kere, J.; Klingberg, T. Influence of the COMT genotype on working memory and brain activity changes during development. Biol. Psychiatry, 2011, 70(3), 222-229.
57. Salthouse, T.A. Influence of age on practice effects in longitudinal neurocognitive change. Neuropsychology, 2010, 24(5), 563-572.
58. Mattay, V.S.; Goldberg, T.E.; Sambataro, F.; Weinberger, D.R. Neurobiology of cognitive aging: insights from imaging genetics. Biol. Psychol., 2008, 79(1), 9-22.
59. Bertolino, A.; Rubino, V.; Sambataro, F.; Blasi, G.; Latorre, V.; Fazio, L.; Caforio, G.; Petruzzella, V.; Kolachana, B.; Hariri, A.; Meyer-Lindenberg, A.; Nardini, M.; Weinberger, D.R.; Scarabino, T. Prefrontal-hippocampal coupling during memory processing is modulated by COMT val158met genotype. Biol. Psychiatry, 2006, 60(11), 1250-1258.
60. Mier, D.; Kirsch, P.; Meyer-Lindenberg, A. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol. Psychiatry, 2010, 15(9), 918-927.
61. Goldman-Rakic, P.S.; Muly, E.C. 3rd; Williams, G.V. D(1) receptors in prefrontal cells and circuits. Brain Res. Brain Res. Rev., 2000, 31(2-3), 295-301.
62. Chen, J.; Lipska, B.K.; Halim, N.; Ma, Q.D.; Matsumoto, M.; Melhem, S.; Kolachana, B.S.; Hyde, T.M.; Herman, M.M.; Apud, J.; Egan, M.F.; Kleinman, J.E.; Weinberger, D.R. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet., 2004, 75(5), 807-821.
63. Tan, H.Y.; Chen, Q.; Sust, S.; Buckholtz, J.W.; Meyers, J.D.; Egan, M.F.; Mattay, V.S.; Meyer-Lindenberg, A.; Weinberger, D.R.; Callicott, J.H. Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proc. Natl. Acad. Sci. USA, 2007, 104(30), 12536-12541.
64. Sambataro, F.; Fazio, L.; Taurisano, P.; Gelao, B.; Porcelli, A.; Mancini, M.; Sinibaldi, L.; Ursini, G.; Masellis, R.; Caforio, G.; Di Giorgio, A.; Niccoli-Asabella, A.; Popolizio, T.; Blasi, G.; Bertolino, A. DRD2 Genotype-Based Variation of Default Mode Network Activity and of Its Relationship with Striatal DAT Binding. Schizophr. Bull., 2011. Available at: http://dx.doi.org/10.1093/schbul/sbr128.
65. Stokes, P.R.; Rhodes, R.A.; Grasby, P.M.; Mehta, M.A. The Effects of The COMT val(108/158)met Polymorphism on BOLD Activation During Working Memory, Planning, and Response Inhibition: A Role for The Posterior Cingulate Cortex? Neuropsychopharmacology, 2011, 36(4), 763-71.
66. Wolf, N.D.; Sambataro, F.; Vasic, N.; Frasch, K.; Schmid, M.; Schonfeldt-Lecuona, C.; Thomann, P.A.; Wolf, R.C. Dysconnectivity of multiple resting-state networks in patients with schizophrenia who have persistent auditory verbal hallucinations. J. Psychiatry Neurosci., 2011, 36(6), 366-374.
67. Sambataro, F.; Reed, J.D.; Murty, V.P.; Das, S.; Tan, H.Y.; Callicott, J.H.; Weinberger, D.R.; Mattay, V.S. Catechol-Omethyltransferase valine(158)methionine polymorphism modulates brain networks underlying working memory across adulthood. Biol. Psychiatry, 2009, 66(6), 540-548.
68. Wolf, R.C.; Plichta, M.M.; Sambataro, F.; Fallgatter, A.J.; Jacob, C.; Lesch, K.P.; Herrmann, M.J.; Schonfeldt-Lecuona, C.; Connemann, B.J.; Gron, G.; Vasic, N. Regional brain activation changes and abnormal functional connectivity of the ventrolateral prefrontal cortex during working memory processing in adults with attention-deficit/hyperactivity disorder. Hum. Brain Mapp., 2009, 30(7), 2252-2266.
69. Wolf, R.C.; Sambataro, F.; Lohr, C.; Steinbrink, C.; Martin, C.; Vasic, N. Functional brain network abnormalities during verbal working memory performance in adolescents and young adults with dyslexia. Neuropsychologia, 2010, 48(1), 309-318.
70. Wolf, R.C.; Sambataro, F.; Vasic, N.; Schmid, M.; Thomann, P.A.; Bienentreu, S.D.; Wolf, N.D. Aberrant connectivity of resting-state networks in borderline personality disorder. J. Psychiatry Neurosci., 2011, 36(2), 100-150.
71. Sambataro, F.; Blasi, G.; Fazio, L.; Caforio, G.; Taurisano, P.; Romano, R.; Di Giorgio, A.; Gelao, B.; Lo Bianco, L.; Papazacharias, A.; Popolizio, T.; Nardini, M.; Bertolino, A. Treatment with olanzapine is associated with modulation of the default mode network in patients with Schizophrenia. Neuropsychopharmacology, 2010, 35(4), 904-912.
72. Cerasa, A.; Gioia, M.C.; Labate, A.; Liguori, M.; Lanza, P.; Quattrone, A. Impact of catechol-O-methyltransferase Val(108/158) Met genotype on hippocampal and prefrontal gray matter volume. Neuroreport, 2008, 19(4), 405-508.
73. Honea, R.; Verchinski, B.A.; Pezawas, L.; Kolachana, B.S.; Callicott, J.H.; Mattay, V.S.; Weinberger, D.R.; Meyer-Lindenberg, A. Impact of interacting functional variants in COMT on regional gray matter volume in human brain. Neuroimage, 2009, 45(1), 44-51.
74. Rowe, J.B.; Hughes, L.; Williams-Gray, C.H.; Bishop, S.; Fallon, S.; Barker, R.A.; Owen, A.M. The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease. Neurobiol. Aging, 2010, 31(6), 1064-1068.
75. Mattay, V.S.; Goldberg, T.E.; Fera, F.; Hariri, A.R.; Tessitore, A.; Egan, M.F.; Kolachana, B.; Callicott, J.H.; Weinberger, D.R. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc. Natl. Acad. Sci. USA, 2003, 100(10), 6186-6191.
76. ] Ceravolo, R.; Piccini, P.; Bailey, D. L.; Jorga, K.M.; Bryson, H.; Brooks, D.J. 18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease. Synapse, 2002, 43(3), 201-207.
77. Apud, J.A.; Mattay, V.; Chen, J.; Kolachana, B.S.; Callicott, J.H.; Rasetti, R.; Alce, G.; Iudicello, J.E.; Akbar, N.; Egan, M.F.; Goldberg, T.E.; Weinberger, D.R. Tolcapone improves cognition and cortical information processing in normal human subjects. Neuropsychopharmacology, 2007, 32(5), 1011-1020.
78. Giakoumaki, S.G.; Roussos, P.; Bitsios, P. Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism. Neuropsychopharmacology, 2008, 33(13), 3058-3068.
79. Roussos, P.; Giakoumaki, S.G.; Bitsios, P. Tolcapone effects on gating, working memory, and mood interact with the synonymous catechol-O-methyltransferase rs4818c/g polymorphism. Biol. Psychiatry, 2009, 66(11), 997-1004.
80. Foltynie, T.; Goldberg, T.E.; Lewis, S.G.; Blackwell, A.D.; Kolachana, B.S.; Weinberger, D.R.; Robbins, T.W.; Barker, R.A. Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism. Mov. Disord., 2004, 19(8), 885-891.
81. Williams-Gray, C.H.; Hampshire, A.; Robbins, T.W.; Owen, A.M.; Barker, R.A. Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease. J. Neurosci., 2007, 27(18), 4832-4838.
82. Williams-Gray, C.H.; Hampshire, A.; Barker, R.A.; Owen, A.M. Attentional control in Parkinson's disease is dependent on COMT val 158 met. genotype. Brain, 2008, 131(Pt 2), 397-408.
83. Onur, O.A.; Piefke, M.; Lie, C.H.; Thiel, C.M.; Fink, G.R. Modulatory Effects of Levodopa on Cognitive Control in Young but not in Older Subjects: A Pharmacological fMRI Study. J. Cogn. Neurosci., 2011, 23(10), 2797-2810.
84. Liljequist, R.; Haapalinna, A.; Ahlander, M.; Li, Y.H.; Mannisto, P.T. Catechol O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats. Behav. Brain Res., 1997, 82(2), 195-202.
85. Deary, I.J.; Wright, A.F.; Harris, S.E.; Whalley, L.J.; Starr, J.M. Searching for genetic influences on normal cognitive ageing. Trends Cogn. Sci., 2004, 8(4), 178-184.
86. Egan, M.F.; Kojima, M.; Callicott, J.H.; Goldberg, T.E.; Kolachana, B.S.; Bertolino, A.; Zaitsev, E.; Gold, B.; Goldman, D.; Dean, M.; Lu, B.; Weinberger, D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 2003, 112(2), 257-269.
87. Webster, M.J.; Herman, M.M.; Kleinman, J.E.; Shannon Weickert, C. BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. Gene Expr. Patterns, 2006, 6(8), 941-951.
88. Sohrabji, F.; Lewis, D.K. Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front. Neuroendocrinol., 2006, 27(4), 404-414.
89. Pezawas, L.; Verchinski, B.A.; Mattay, V.S.; Callicott, J.H.; Kolachana, B.S.; Straub, R.E.; Egan, M.F.; Meyer-Lindenberg, A.; Weinberger, D.R. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J. Neurosci., 2004, 24(45), 10099-10102.
90. Hariri, A.R.; Goldberg, T.E.; Mattay, V.S.; Kolachana, B.S.; Callicott, J.H.; Egan, M.F.; Weinberger, D.R. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci., 2003, 23(17), 6690-6694.
91. Sambataro, F.; Murty, V.P.; Lemaitre, H.S.; Reed, J.D.; Das, S.; Goldberg, T.E.; Callicott, J.H.; Weinberger, D.R.; Mattay, V.S. BDNF modulates normal human hippocampal ageing [corrected]. Mol. Psychiatry, 2010, 15(2), 116-118.
92. Miyajima, F.; Ollier, W.; Mayes, A.; Jackson, A.; Thacker, N.; Rabbitt, P.; Pendleton, N.; Horan, M.; Payton, A. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes Brain Behav., 2008, 7(4), 411-417.
93. Cheng, C.Y.; Hong, C.J.; Liu, H.C.; Liu, T.Y.; Tsai, S.J. Study of the association between Alzheimer's disease and angiotensinconverting enzyme gene polymorphism using DNA from lymphocytes. Eur. Neurol., 2002, 47(1), 26-29.
94. Elkins, J.S.; Douglas, V.C.; Johnston, S.C. Alzheimer disease risk and genetic variation in ACE: a meta-analysis. Neurology, 2004, 62(3), 363-368.
95. Bartres-Faz, D.; Junque, C.; Clemente, I.C.; Lopez-Alomar, A.; Valveny, N.; Lopez-Guillen, A.; Lopez, T.; Cubells, M.J.; Moral, P. Angiotensin I converting enzyme polymorphism in humans with age-associated memory impairment: relationship with cognitive performance. Neurosci. Lett., 2000, 290(3), 177-180.
96. Stewart, R.; Powell, J.; Prince, M.; Mann, A. ACE genotype and cognitive decline in an African-Caribbean population. Neurobiol. Aging, 2004, 25(10), 1369-1375.
97. Efimova, I.Y.; Efimova, N.Y.; Triss, S.V.; Lishmanov, Y.B. Brain perfusion and cognitive function changes in hypertensive patients. Hypertens. Res., 2008, 31(4), 673-678.
98. Amouyel, P.; Richard, F.; Cottel, D.; Amant, C.; Codron, V.; Helbecque, N. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci. Lett., 1996, 217(2-3), 203-205.
99. Richard, F.; Berr, C.; Amant, C.; Helbecque, N.; Amouyel, P.; Alperovitch, A. Effect of the angiotensin I-converting enzyme I/D polymorphism on cognitive decline. The EVA Study Group. Neurobiol. Aging, 2000, 21(1), 75-80.
100. Bray, N.J.; Buckland, P.R.; Williams, N.M.; Williams, H.J.; Norton, N.; Owen, M.J.; O'Donovan, M.C. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am. J. Hum. Genet., 2003, 73(1), 152-161.
101. Meyer-Lindenberg, A.; Nichols, T.; Callicott, J.H.; Ding, J.; Kolachana, B.; Buckholtz, J.; Mattay, V.S.; Egan, M.; Weinberger, D.R. Impact of complex genetic variation in COMT on human brain function. Mol. Psychiatry, 2006, 11(9), 867-877.
102. Nackley, A.G.; Shabalina, S.A.; Tchivileva, I.E.; Satterfield, K.; Korchynskyi, O.; Makarov, S.S.; Maixner, W.; Diatchenko, L. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science, 2006, 314(5807), 1930-1933.
103. Diatchenko, L.; Slade, G.D.; Nackley, A.G.; Bhalang, K.; Sigurdsson, A.; Belfer, I.; Goldman, D.; Xu, K.; Shabalina, S.A.; Shagin, D.; Max, M.B.; Makarov, S.S.; Maixner, W. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum. Mol. Genet., 2005, 14(1), 135-143.
104. Barnett, J.H.; Heron, J.; Goldman, D.; Jones, P.B.; Xu, K. Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children. Am. J. Psychiatry, 2009, 166(8), 909-916.
105. Stein, D.J.; Newman, T.K.; Savitz, J.; Ramesar, R. Warriors versus worriers: the role of COMT gene variants. CNS Spectr., 2006, 11(10), 745-748.
106. Drabant, E.M.; Hariri, A.R.; Meyer-Lindenberg, A.; Munoz, K.E.; Mattay, V.S.; Kolachana, B.S.; Egan, M.F.; Weinberger, D.R. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch. Gen. Psychiatry, 2006, 63(12), 1396-1406.
107. Becker, J.B. Oestrogen effects on dopaminergic function in striatum. Novartis Found. Symp., 2000, 230, 134-145; discussion 145-154.
108. Shansky, R.M.; Glavis-Bloom, C.; Lerman, D.; McRae, P.; Benson, C.; Miller, K.; Cosand, L.; Horvath, T.L.; Arnsten, A.F. Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction. Mol. Psychiatry, 2004, 9(5), 531-538.
109. Jacobs, E.; D'Esposito, M. Estrogen shapes dopamine-dependent cognitive processes: implications for women's health. J. Neurosci., 2011, 31(14), 5286-5293.
110. Xie, T.; Ho, S.L.; Ramsden, D. Characterization and implications of estrogenic down-regulation of human catechol-Omethyltransferase gene transcription. Mol. Pharmacol., 1999, 56(1), 31-38.
111. Jiang, H.; Xie, T.; Ramsden, D.B.; Ho, S.L. Human catechol-Omethyltransferase down-regulation by estradiol. Neuropharmacology, 2003, 45(7), 1011-1018.
112. Laakso, A.; Vilkman, H.; Bergman, J.; Haaparanta, M.; Solin, O.; Syvalahti, E.; Salokangas, R.K.; Hietala J. Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Biol. Psychiatry, 2002, 52(7), 759-763.
113. Mozley, L.H.; Gur, R.C.; Mozley, P.D.; Gur, R.E. Striatal dopamine transporters and cognitive functioning in healthy men and women. Am. J. Psychiatry, 2001, 158(9), 1492-1499.
114. Masuda, M.; Tsunoda, M.; Imai, K. Low catechol-Omethyltransferase activity in the brain and blood pressure regulation. Biol. Pharmaceut. Bull., 2006, 29(2), 202-205.
115. Annerbrink, K.; Westberg, L.; Nilsson, S.; Rosmond, R.; Holm, G.; Eriksson, E. Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men. Metabolism, 2008, 57(5), 708-711.
116. Htun, N.C.; Miyaki, K.; Song, Y.; Ikeda, S.; Shimbo, T.; Muramatsu, M. Association of the catechol-O-methyl transferase gene Val158Met polymorphism with blood pressure and prevalence of hypertension: interaction with dietary energy intake. Am. J. Hypertens., 2011, 24(9), 1022-1026.
117. Qiu, C.; Winblad, B.; Fratiglioni, L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol., 2005, 4(8), 487-499.
118. Witte, A.V.; Jansen, S.; Schirmacher, A.; Young, P.; Floel, A. COMT Val158Met Polymorphism Modulates Cognitive Effects of Dietary Intervention. Front. Aging Neurosci., 2010, 2, 146.
119. Hajjar, I.; Kritchevsky, S.; Newman, A.B.; Li, R.; Yaffe, K.; Simonsick, E.M.; Lipsitz, L.A.; Health, A.; Body Composition, S. Renin angiotensin system gene polymorphisms modify angiotensin-converting enzyme inhibitors' effect on cognitive function: the health, aging and body composition study. J. Am. Geriatr. Soc., 2010, 58(6), 1035-1042.
120. Reynolds, C.A.; Gatz, M.; Berg, S.; Pedersen, N.L. Genotypeenvironment interactions: cognitive aging and social factors. Twin Res. Hum. Genet., 2007, 10(2), 241-254.